Cargando…

Interleukin 17 and Treg – a common pathomechanism and a new target of therapy in rheumatic diseases and depression

Detalles Bibliográficos
Autores principales:	Gałecki, Piotr, Kowalczyk, Małgorzata
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie 2018
Materias:	Editorial Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6142021/ https://www.ncbi.nlm.nih.gov/pubmed/30237623 http://dx.doi.org/10.5114/reum.2018.77969

Ejemplares similares

Unresolved Systemic Inflammation, Long COVID, and the Common Pathomechanisms of Somatic and Psychiatric Comorbidity
por: Liang, Chih-Sung, et al.
Publicado: (2022)

Is Interleukin 17 (IL-17) Expression A Common Point in the Pathogenesis of Depression and Obesity?
por: Bliźniewska-Kowalska, Katarzyna, et al.
Publicado: (2020)

Role of Interleukin-17A in the Pathomechanisms of Periodontitis and Related Systemic Chronic Inflammatory Diseases
por: Feng, Yi, et al.
Publicado: (2022)

Targeting interleukin-17 receptors
por: Lee, Wen-Hwa, et al.
Publicado: (2015)

The role of interleukin genes in the course of depression
por: Talarowska, Monika, et al.
Publicado: (2016)

Serum KIBRA mRNA and Protein Expression and Cognitive Functions in Depression
por: Talarowska, Monika, et al.
Publicado: (2016)

Hemorrhagic stroke—Pathomechanisms of injury and therapeutic options
por: Chaudhary, Neeraj, et al.
Publicado: (2019)

Pathomechanisms of Vascular Depression in Older Adults
por: Jellinger, Kurt A.
Publicado: (2021)

Beyond interleukin-17-targeted therapy: Complexity of environment-genetics-immunology needs to be addressed
por: Wu, Xin, et al.
Publicado: (2022)

Autophagy as an Emerging Common Pathomechanism in Inherited Peripheral Neuropathies
por: Haidar, Mansour, et al.
Publicado: (2017)

Neuroimmunology and (Epi)Genetics in Depressive Disorders
por: Gałecki, Piotr, et al.
Publicado: (2021)

Butyrate inhibits interleukin-17 and generates Tregs to ameliorate colorectal colitis in rats
por: Zhang, Mingming, et al.
Publicado: (2016)

A common pathomechanism in GMAP-210– and LBR-related diseases
por: Wehrle, Anika, et al.
Publicado: (2018)

Nucleolar and Ribosomal Dysfunction—A Common Pathomechanism in Childhood Progerias?
por: Phan, Tamara, et al.
Publicado: (2019)

Common Factors of Alzheimer’s Disease and Rheumatoid Arthritis—Pathomechanism and Treatment
por: Trzeciak, Paulina, et al.
Publicado: (2021)

Ribosomal Dysfunction Is a Common Pathomechanism in Different Forms of Trichothiodystrophy
por: Zhu, Gaojie, et al.
Publicado: (2023)

The potential role of 'non-rheumatic’ therapies in rheumatic disease
por: Massarotti, Elena M, et al.
Publicado: (2013)

Rheumatic and oncological diseases – common challenges
por: Jeziorski, Krzysztof
Publicado: (2017)

Pathomechanisms of Immunological Disturbances in β-Thalassemia
por: Gluba-Brzózka, Anna, et al.
Publicado: (2021)

HPA Axis in the Pathomechanism of Depression and Schizophrenia: New Therapeutic Strategies Based on Its Participation
por: Mikulska, Joanna, et al.
Publicado: (2021)

Immune to happiness – inflammatory process indicators and depressive personality traits
por: Talarowska, Monika E., et al.
Publicado: (2019)

Low-dose Interleukin-2 For Psoriasis Therapy Based on the Regulation of Th17/Treg Cell Balance in Peripheral Blood
por: Qiao, Zusha, et al.
Publicado: (2023)

Sphingolipids as a new factor in the pathomechanism of preeclampsia – Mass spectrometry analysis
por: Charkiewicz, Karol, et al.
Publicado: (2017)

Interleukin 1 level, cognitive performance, and severity of depressive symptoms in patients treated with systemic anticancer therapy: a prospective study
por: Jasionowska, Justyna, et al.
Publicado: (2019)

Treg/IL-17 Ratio and Treg Differentiation in Patients with COPD
por: Jin, Yang, et al.
Publicado: (2014)

The Dynamics of Treg/Th17 and the Imbalance of Treg/Th17 in Clonorchis sinensis-Infected Mice
por: Yan, Chao, et al.
Publicado: (2015)

Infectious Etiologies of Parkinsonism: Pathomechanisms and Clinical Implications
por: Limphaibool, Nattakarn, et al.
Publicado: (2019)

Interleukin-17 Can Be the Target of Novel Treatment Strategies for Particulate Matter–Induced Allergic Diseases
por: Kim, Byeong-Gon, et al.
Publicado: (2021)

Neutralization of interleukin-17 suppresses allergic rhinitis symptoms by downregulating Th2 and Th17 responses and upregulating the Treg response
por: Gu, Zhao Wei, et al.
Publicado: (2017)

The role of miRNA in diagnosing and clarifying the pathomechanisms in major depressive disorder
por: Ho, C. S., et al.
Publicado: (2023)

New Insights into Pathomechanisms and Treatment Possibilities for Lung Silicosis
por: Adamcakova, Jana, et al.
Publicado: (2021)

Interleukin-17A and interleukin-23 in morphea
por: Dańczak-Pazdrowska, Aleksandra, et al.
Publicado: (2012)

Pathomechanisms of Paraneoplastic Myasthenia Gravis
por: Ströbel, Philipp, et al.
Publicado: (2003)

Overview on the pathomechanisms of allergic rhinitis
por: Pawankar, Ruby, et al.
Publicado: (2011)

Microscopic enteritis and pathomechanism of malabsorption
por: Rostami, Kamran, et al.
Publicado: (2010)

Novel pathomechanisms in inflammatory neuropathies
por: Schafflick, David, et al.
Publicado: (2017)

Pathomechanisms in schwannoma development and progression
por: Helbing, Dario-Lucas, et al.
Publicado: (2020)

Pathomechanism of intervertebral disc degeneration
por: Oichi, Takeshi, et al.
Publicado: (2020)

Pathomechanisms of AERD—Recent Advances
por: Lyly, Annina, et al.
Publicado: (2021)

Th17/Treg Imbalance and Atherosclerosis
por: He, Xin, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_l25i4bg1941rdtc32761oi0bs3